SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 49 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $465,000 | -60.3% | 483,711 | -50.9% | 0.00% | – |
| Q1 2022 | $1,172,000 | -62.3% | 985,231 | +3.4% | 0.00% | – |
| Q4 2021 | $3,107,000 | -18.9% | 953,200 | +11.1% | 0.00% | -100.0% |
| Q3 2021 | $3,833,000 | -27.2% | 857,646 | -11.3% | 0.00% | 0.0% |
| Q2 2021 | $5,267,000 | -15.5% | 966,448 | +16.0% | 0.00% | 0.0% |
| Q1 2021 | $6,230,000 | -2.7% | 833,008 | +41.2% | 0.00% | 0.0% |
| Q4 2020 | $6,402,000 | +24.7% | 590,102 | +1.6% | 0.00% | 0.0% |
| Q3 2020 | $5,133,000 | -14.6% | 580,709 | +3.0% | 0.00% | 0.0% |
| Q2 2020 | $6,010,000 | +103.5% | 563,801 | +13.2% | 0.00% | 0.0% |
| Q1 2020 | $2,954,000 | -55.1% | 498,187 | -47.6% | 0.00% | 0.0% |
| Q4 2019 | $6,572,000 | +40.3% | 951,092 | +110.7% | 0.00% | 0.0% |
| Q3 2019 | $4,685,000 | +13.5% | 451,425 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $4,129,000 | +55.5% | 445,922 | +53.5% | 0.00% | 0.0% |
| Q1 2019 | $2,655,000 | -4.5% | 290,531 | -41.8% | 0.00% | – |
| Q4 2018 | $2,780,000 | +3.1% | 499,336 | +120.5% | 0.00% | -100.0% |
| Q3 2018 | $2,696,000 | +22.9% | 226,434 | +5.3% | 0.00% | 0.0% |
| Q2 2018 | $2,194,000 | +3.3% | 214,944 | +31.4% | 0.00% | 0.0% |
| Q1 2018 | $2,123,000 | +128.0% | 163,567 | +70.8% | 0.00% | – |
| Q4 2017 | $931,000 | -33.3% | 95,755 | +0.9% | 0.00% | -100.0% |
| Q3 2017 | $1,396,000 | +3.6% | 94,891 | +13.2% | 0.00% | 0.0% |
| Q2 2017 | $1,348,000 | +111.3% | 83,821 | +109.2% | 0.00% | – |
| Q1 2017 | $638,000 | +46.7% | 40,058 | +11.8% | 0.00% | – |
| Q4 2016 | $435,000 | -9.6% | 35,836 | +3.1% | 0.00% | – |
| Q3 2016 | $481,000 | – | 34,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |